Drugs
PARIS, FRANCE: Approximately 50 Percent More Patients on Lantus(R) Achieved Target HbA1c Versus Sitagliptin at Study Endpoint; EASIE Study Findings Published in The Lancet ...
PRINCETON, NJ: New Jersey Technology Council CFO Awards Recognize Accomplishments of New Jersey Financial Executives ...
MANCHESTER, NH: MANCHESTER, NH -- (Marketwire) -- 06/07/12 -- (OTCQB: BTHE) (OTCBB: BTHE) ("Boston Therapeutics" or "the Company"), a developer of complex carbohydrates to treat diabetes and oth ...
HORSHAM, PA: Leading Analyst Firm Recognizes Substantial Cost Savings of eSource Business Model and Potential to Transform Clinical Trial Data Capture Processes ...
SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwire) -- 06/05/12 -- Ardea Biosciences, Inc. (NASDAQ: RDEA) ("Ardea"), a biotechnology company focused on the development of small-molecule therapeutics for the tre ...
MISSION VIEJO, CA: MISSION VIEJO, CA -- (Marketwire) -- 06/01/12 -- Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (OTCBB: AOLS), a biotechnology company leveraging significant government funding to develop a platform of n ...
TUCSON, AZ: TUCSON, AZ -- (Marketwire) -- 06/01/12 -- The John Wayne Cancer Institute (JWCI) at Saint John's Health Center in Santa Monica, California selected as an exclusive commercialization partner fo ...
SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwire) -- 05/30/12 -- Genelux Corporation, a privately held, clinical-stage biopharmaceutical company focused on development and commercialization of best-in-class, vaccinia-v ...
SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwire) -- 05/30/12 -- Ardea Biosciences, Inc. (NASDAQ: RDEA) today announced that it has earned a $7.5 million milestone from Bayer HealthCare (Bayer) under the terms of their ...
HOUSTON, TX: HOUSTON, TX -- (Marketwire) -- 05/29/12 -- Z-Pak, the more common name for the antibiotic Azithromycin, is commonly used to treat middle ear infections, strep throat, and other bacterial infections. ...
PARSIPPANY, NJ: PARSIPPANY, NJ -- (Marketwire) -- 05/29/12 -- The Medicines Company (NASDAQ: MDCO) will present at the Jefferies 2012 Global Healthcare Conference on Monday, June 4th in New York City beginning at 4p ...
OSLO, NORWAY: Animal Studies Indicate Vacc-C5 Generates Immune Responses to HIV, Similar to Those in HIV Patients who Naturally Suppress the Virus ...
TORONTO, CANADA: TORONTO, CANADA -- (Marketwire) -- 05/29/12 -- Soricimed Biopharma Inc., a private company developing novel cancer therapeutics and diagnostics, is pleased to announce that the Investigational New D ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 05/24/12 -- . (TSX VENTURE: SBM)(PINKSHEETS: SRBCF)(FRANKFURT: ZSB), announced today it is confirmed to present at the upcoming BioFinance conference wh ...
BALTIMORE, MD: BALTIMORE, MD -- (Marketwire) -- 05/21/12 -- , a biopharmaceutical company focused on the discovery, development and commercialization of prescription pharmaceuticals whose primary activity is in th ...
WEST PALM BEACH, FL: Phase I Study Is First-in-Human Trial of an Oral VEGFR Tyrosine Kinase Inhibitor (TKI) in Patients With Advanced Solid Tumors ...
NEW YORK, NY: NEW YORK, NY -- (Marketwire) -- 05/15/12 -- (OTCBB: KDUS) announced today financial results for the first quarter ended March 31, 2012.Revenues for the first quarter of 2012 were $0, compared to $0 ...
